ADC Therapeutics SA (ADCT)
undefined
undefined%
At close: undefined
1.88
0.53%
After-hours Dec 13, 2024, 07:50 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Revenue 69.56M 209.91M 33.92M - 2.34M 1.14M 1.80M
Cost of Revenue 2.53M 4.58M 1.39M 1.97M 107.54M 118.09M 85.53M
Gross Profit 67.03M 205.33M 32.52M -1.97M -105.20M -116.95M -83.73M
Operating Income -165.99M -123.63M -261.72M -219.26M -119.40M -125.94M -91.67M
Interest Income 10.54M 17.97M 66.00K 832.00K 2.25M 2.86M 1.03M
Pretax Income -195.42M -154.66M -251.50M -245.96M -115.90M -122.87M -89.81M
Net Income -240.05M -155.80M -230.03M -246.29M -116.48M -123.10M -89.86M
Selling & General & Admin 105.89M 141.06M 136.24M 77.23M 13.81M 8.60M 7.81M
Research & Development 127.13M 187.90M 158.00M 142.03M 107.54M 118.31M 85.53M
Other Expenses - 14.58M 28.49M -46.40M 388.00K 166.00K 137.00K
Operating Expenses 233.01M 328.96M 294.24M 219.26M 121.74M 127.08M 93.47M
Interest Expense 46.33M 36.92M 18.34M 4.93M 156.00K - -
Selling & Marketing Expenses 57.46M 69.05M 64.78M 22.10M - - -
Cost & Expenses 235.54M 333.54M 295.64M 219.26M 121.74M 127.08M 93.47M
Income Tax 39.11M 1.14M -21.48M 327.00K 582.00K 224.00K 48.00K
Shares Outstanding (Basic) 81.71M 78.15M 76.75M 65.41M 66.87M 53.83M 58.85M
Shares Outstanding (Diluted) 81.71M 78.15M 76.75M 65.41M 66.87M 53.83M 58.85M
EPS (Basic) -2.94 -1.99 -3 -3.77 -1.74 -2.29 -1.53
EPS (Diluted) -2.94 -1.99 -3 -3.77 -1.74 -2.29 -1.53
EBITDA -146.76M -108.06M -223.72M -219.26M -114.10M -122.36M -91.33M
Depreciation & Amortization 3.27M 2.39M 2.63M 1.97M 1.65M 513.00K 341.00K